Dendrigel 1.5mg Ophthalmic Gel
Marketer
Berry & Herbs Pharma Pvt Ltd
Salt Composition
Ganciclovir (1.5mg)
Overview Dendrigel 1.5mg Ophthalmic Gel
Ganciclovir 1.5mg ophthalmic gel is an antiviral medication indicated for treating cytomegalovirus (CMV) infections in immunocompromised individuals post-organ or bone marrow transplant. This formulation helps prevent vision loss from CMV retinitis, a severe ocular infection. For topical use only, apply as directed by your physician. Always wash hands before and after administration. Hold the applicator near the eye, avoiding contact, gently squeezing a small amount into the lower eyelid. Mild, transient eye irritation may occur; however, this usually resolves spontaneously. Report persistent irritation to your doctor. Refrain from wearing contact lenses during treatment.
Uses of Dendrigel 1.5mg Ophthalmic Gel
CMV Infection
Major Benefits of Dendrigel 1.5mg Ophthalmic Gel:
Apply this medication topically only. Administer as prescribed by your physician, adhering to the dosage and treatment schedule provided. Consult the product label for application instructions prior to use. Position the applicator near, but not touching, the eye. Carefully dispense the medication into the lower conjunctival sac.
Common Side effects of Dendrigel 1.5mg Ophthalmic Gel:
- Eye irritation
How to use Dendrigel 1.5mg Ophthalmic Gel:
Apply this medication externally only. Administer as directed by your physician, following the prescribed dosage and treatment schedule. Consult the product label for application instructions. Keep the applicator tip near, but not touching, the eye. Carefully dispense the medication into the lower conjunctival sac.
How Dendrigel 1.5mg Ophthalmic Gel works:
Ocuvir 1.5mg ophthalmic gel combats viral eye infections by inhibiting viral replication on the corneal surface. This antiviral medication halts further virus production, thereby resolving the infection.
SAFETY ADVICE
AlcoholNone
No drug interactions identified.
PregnancyCONSULT YOUR DOCTOR
The use of Dendrigel 1.5mg Ophthalmic Gel during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to recommending its use. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Dendrigel 1.5mg Ophthalmic Gel while breastfeeding is likely inadvisable. Insufficient human evidence indicates potential drug transfer into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Using Dendrigel 1.5mg Ophthalmic Gel may result in adverse reactions impacting driving capabilities. These potential effects include drowsiness, dizziness, disorientation, tremors, loss of equilibrium, or seizures.
KidneyNone
No known drug interactions.
LiverNone
No known drug interactions.
What if you forget to take Dendrigel 1.5mg Ophthalmic Gel :
Should you forget a dose of Dendrigel 1.5mg Ophthalmic Gel, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dendrigel 1.5mg Ophthalmic Gel
| Label | Value |
|---|---|
| Chemical Type | Analogous nucleoside |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Behavior Class | Non-HIV antiviral medications |
3,018 People bought this recently